Nucleic Acid Isolation & Purification Market Size & Growth Forecast 2027–2036, By Segments (Type, Application, Product, Method, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Nucleic Acid Isolation & Purification Market size was valued at USD 6.05 Billion in 2026 and is anticipated to grow at 8.16% CAGR from 2027 to 2036, crossing USD 13.26 Billion by 2036. The industry revenue for 2027 is assessed at USD 6.47 Billion.
Get more details on this report
Request Free Sample ReportNucleic Acid Isolation & Purification Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 40.82% in 2026, driven by advanced laboratory infrastructure, strong life sciences capabilities, automation, and widespread molecular diagnostics and genomics adoption.
- Asia Pacific is expanding rapidly through investments in biotechnology, genomics, molecular diagnostics, and laboratory infrastructure, alongside rising genetic testing and infectious disease research.
Segment Momentum
- RNA isolation & purification accounted for 55.76% of the market in 2026, supported by growing use in gene expression studies, infectious disease testing, transcriptomics, and molecular biology research.
- Diagnostics is the largest and fastest-growing application segment, driven by increasing adoption of molecular diagnostics for infectious diseases, genetic disorders, early disease detection, and personalized healthcare.
Market Expansion Drivers
- Rising molecular diagnostics adoption accelerating demand for high-purity nucleic acid extraction solutions
- Expanding genomics and biotechnology research investments driving laboratory workflow automation adoption
- Growth in infectious disease surveillance programs increasing nucleic acid testing utilization globally
Leading Market Participants
- Major companies in the nucleic acid isolation & purification market include QIAGEN N.V. (Germany), Thermo Fisher Scientific Inc. (USA), Illumina Inc. (USA), Danaher Corporation (USA), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies Inc. (USA), Bio-Rad Laboratories Inc. (USA), Takara Bio Inc. (Japan), Promega Corporation (USA), Merck KGaA (Germany)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 6.05 Billion
- 2027 Estimated Market Size: USD 6.47 Billion
- Projected Market Size: USD 13.26 Billion by 2036
- Growth Forecast: 8.16% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: RNA Isolation & Purification (Type) | Diagnostics (Application) | Reagents & Kits (Product) | Magnetic Beads (Method) | Hospitals and Diagnostic Centers (End-use)
- Emerging Opportunity Segment: DNA Isolation & Purification (Type) | Diagnostics (Application) | Reagents & Kits (Product) | Magnetic Beads (Method) | Hospitals and Diagnostic Centers (End-use)
Market Growth Drivers and Industry Trends
Rising molecular diagnostics adoption accelerating demand for high-purity nucleic acid extraction solutions
The growing use of molecular diagnostics across clinical testing and disease detection applications is creating greater demand for reliable sample preparation processes, which will drive the nucleic acid isolation & purification market growth. As diagnostic laboratories increasingly depend on accurate genetic material analysis, the need for high-quality extracted DNA and RNA with consistent purity levels is becoming essential for improving test performance. Advanced extraction workflows help laboratories manage complex samples while supporting applications such as pathogen identification, genetic screening, and precision diagnostics.
Expanding genomics and biotechnology research investments driving laboratory workflow automation adoption
Increasing investments in genomics studies and biotechnology innovation are transforming laboratory operations, where automation adoption will propel the nucleic acid isolation & purification market growth. Research institutions and biotechnology laboratories are prioritizing scalable workflows that reduce manual handling, improve reproducibility, and support higher sample processing volumes. Automated purification platforms enable efficient integration with sequencing and molecular analysis pipelines, allowing researchers to accelerate discovery activities while maintaining workflow consistency.
Growth in infectious disease surveillance programs increasing nucleic acid testing utilization globally
The nucleic acid isolation & purification market growth is driven by expanding infectious disease monitoring initiatives that require dependable testing capabilities across healthcare systems and public health laboratories. Increased focus on outbreak preparedness and continuous pathogen surveillance has strengthened the requirement for efficient nucleic acid extraction methods that support rapid and accurate molecular testing. These solutions enable laboratories to process diverse biological samples effectively, improving their ability to track emerging infectious threats and conduct large-scale diagnostic programs.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising molecular diagnostics adoption accelerating demand for high-purity nucleic acid extraction solutions | 2% | High | North America, Europe | High | Near Term |
| Expanding genomics and biotechnology research investments driving laboratory workflow automation adoption | 1.8% | High | North America, Asia Pacific | High | Near Term |
| Growth in infectious disease surveillance programs increasing nucleic acid testing utilization globally | 1.6% | High | Asia Pacific, Latin America | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the nucleic acid isolation & purification market, North America held the largest share of 40.82% in 2026, reflecting strong biotechnology and pharmaceutical research capabilities, advanced laboratory infrastructure, and widespread use of molecular diagnostic and genomics technologies. Increasing research activity involving DNA and RNA analysis is sustaining demand for efficient sample preparation solutions. The region’s established life sciences ecosystem, adoption of automated laboratory workflows, and growing emphasis on precision medicine and molecular testing further support its leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to register the fastest growth as investments in biotechnology, genomics, molecular diagnostics, and life sciences research continue to expand. Improvements in laboratory infrastructure and increasing adoption of advanced diagnostic technologies are broadening the need for reliable nucleic acid preparation workflows. Growing healthcare capabilities across emerging economies and greater research activity in infectious disease testing, genetic analysis, and personalized medicine are also creating favorable conditions for market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
High-Throughput Genomics DemandIn the U.S., nucleic acid isolation and purification systems are driven by strong demand from genomics research, clinical diagnostics, and biotech workflows. Laboratories increasingly adopt automated platforms to improve sample consistency, reduce processing time, and support large-scale molecular testing applications.
Germany 🇩🇪
Standardized Lab AutomationGermany’s nucleic acid isolation and purification market emphasizes standardized laboratory workflows and high-quality automated extraction systems. Research institutes and diagnostic labs in Germany prioritize precision, reproducibility, and compliance with stringent molecular testing protocols.
Japan 🇯🇵
Precision Molecular WorkflowJapan’s nucleic acid isolation and purification market is shaped by demand for highly precise and contamination-controlled molecular workflows. Laboratories in Japan focus on compact automated systems that support clinical diagnostics and advanced life sciences research applications.
South Korea 🇰🇷
Biotech Platform ExpansionSouth Korea is expanding nucleic acid isolation and purification capabilities through rapid growth in biotech research and clinical molecular diagnostics. Facilities increasingly adopt integrated extraction platforms that enhance throughput and support multi-omics research applications.
France 🇫🇷
Clinical Molecular ScalingFrance’s nucleic acid isolation and purification market is supported by expanding clinical molecular testing programs and hospital laboratory upgrades. Institutions in France prioritize reliable extraction systems that ensure accuracy and scalability in diagnostic and research workflows.
Italy 🇮🇹
Diagnostic Lab UpgradesItaly’s nucleic acid isolation and purification market is driven by gradual upgrades in diagnostic laboratory infrastructure. Healthcare and research institutions in Italy focus on efficient and cost-effective extraction systems that support routine molecular testing and biomedical research activities.
Segment Leadership and Growth Trends
Nucleic Acid Isolation & Purification Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: RNA Isolation & Purification (Largest Segment) vs DNA Isolation & Purification (Fastest-Growing Segment)
The RNA isolation & purification segment dominated the nucleic acid isolation & purification market, accounting for 55.76% of the market share in 2026. Its leading position is driven by the growing importance of RNA analysis in gene expression studies, infectious disease testing, transcriptomics, and molecular biology research. Expanding applications in advanced life science research and increasing adoption of RNA-based analytical techniques continue to strengthen demand for efficient isolation and purification solutions.
The DNA isolation & purification segment is expected to witness the fastest growth during the forecast period. Rising utilization of genomic analysis, expanding applications in genetic testing, and increasing demand for high-quality DNA samples in clinical diagnostics and biomedical research are supporting market expansion. Ongoing advancements in molecular technologies and precision medicine are further accelerating the adoption of DNA isolation and purification workflows.
Application Segment Analysis: Diagnostics (Largest & Fastest-Growing Segment)
The diagnostics segment held the largest share of 36.72% in 2026 and is also projected to remain the fastest-growing application in the nucleic acid isolation & purification market. Increasing reliance on molecular diagnostic techniques for the accurate detection of infectious diseases, genetic disorders, and other medical conditions continues to drive demand for high-quality nucleic acid extraction solutions. Growing emphasis on early disease identification, personalized healthcare, and the expanding integration of molecular diagnostics into routine clinical practice further reinforces the segment's leadership and sustained growth.
Product Segment Analysis: Reagents & Kits (Largest &Fastest-Growing Segment)
The nucleic acid isolation & purification market was led by the reagents & kits segment in 2026, and it is also expected to be the fastest-growing product category. The recurring nature of molecular testing creates consistent demand for reagents and kits across research laboratories, diagnostic facilities, and biotechnology applications. Continuous innovation in extraction chemistries, improvements in workflow efficiency, and increasing adoption of automated molecular testing platforms are strengthening the segment's market position while supporting its ongoing expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | RNA Isolation & Purification, DNA Isolation & Purification | RNA Isolation & Purification | DNA Isolation & Purification |
| Application | Diagnostics, Drug Discovery & Development, Precision Medicine, Others | Diagnostics | Diagnostics |
| Product | Reagents & Kits, Instruments | Reagents & Kits | Reagents & Kits |
| Method | Magnetic Beads, Column-based, Reagent-based, Others | Magnetic Beads | Magnetic Beads |
| End-use | Hospitals and Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others | Hospitals and Diagnostic Centers | Hospitals and Diagnostic Centers |
Competitive Landscape and Market Positioning
Leading companies in the nucleic acid isolation & purification market:
- QIAGEN N.V. (Germany)
- Thermo Fisher Scientific, Inc. (USA)
- Illumina, Inc. (USA)
- Danaher Corporation (USA)
- F. Hoffmann-La Roche AG (Switzerland)
- Agilent Technologies, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Takara Bio, Inc. (Japan)
- Promega Corporation (USA)
- Merck KGaA (Germany)
Advances in molecular diagnostics, genomic research, and precision medicine are prompting suppliers to compete by improving workflow efficiency rather than simply expanding reagent portfolios. Competitive positioning increasingly depends on delivering extraction technologies that provide consistent sample quality across diverse biological materials while integrating smoothly with automated laboratory platforms. As laboratories seek higher throughput and reduced manual intervention, manufacturers are investing in scalable purification systems, standardized protocols, and compatibility with downstream analytical techniques. The ability to support research, clinical, and biopharmaceutical applications through flexible and reliable solutions is becoming a defining factor in market differentiation.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Merck | Oct-25 | Merck introduced the MagPrep Viral RNA Isolation Kit and the MagPrep cfDNA Isolation Kit, expanding its portfolio for isolating cell-free DNA from blood samples and viral RNA from biological specimens. |
| Thermo Fisher Scientific | Sep-25 | Thermo Fisher Scientific launched the MagMAX HMW DNA Kit for high-molecular-weight DNA extraction, designed specifically for long-read sequencing applications and automated KingFisher workflows. |
| Thermo Fisher Scientific | Feb-25 | Thermo Fisher Scientific acquired Solventum's purification and filtration business for USD 4.1 billion, strengthening consumables depth and expanding its operational footprint within the life sciences sector. |
| Trilobio | Jan-25 | Trilobio unveiled a whole-laboratory automation platform at SLAS2025, integrating robotics and software to support end-to-end genetic engineering workflows and advance laboratory automation capabilities. |
| Thermo Fisher Scientific | Jul-24 | Thermo Fisher Scientific partnered with the National Cancer Institute on the myeloMATCH precision medicine trial, deploying next-generation sequencing assays to support clinical research initiatives. |
| Beckman Coulter Life Sciences | May-24 | Beckman Coulter Life Sciences collaborated with Watchmaker Genomics to streamline next-generation sequencing library preparation on the Biomek i7 Dual Hybrid Liquid Handler, enhancing automated workflow efficiency. |
| New England Biolabs | Apr-24 | New England Biolabs launched the Monarch Mag Viral DNA/RNA Extraction Kit, optimized for efficient viral nucleic acid isolation from small sample inputs to support high-sensitivity testing workflows. |
| Alpha Laboratories | Jan-24 | Alpha Laboratories partnered with ProtonDx to launch SmartLid, a magnetic lid system that simplifies viral DNA and RNA extraction by integrating lysis, wash, and elution steps into a streamlined workflow. |
| INOVIQ Limited | Jul-23 | INOVIQ Limited entered into a joint marketing agreement with Promega Corporation to co-market INOVIQ's EXO-NET exosome capture technology alongside Promega nucleic acid purification systems, expanding global distribution reach to researchers and clinical laboratories. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Nucleic Acid Isolation & Purification Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Nucleic Acid Isolation & Purification Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow big is the nucleic acid isolation & purification market?
What is the expected industry size of nucleic acid isolation & purification by 2035?
How is molecular diagnostics adoption shaping demand for nucleic acid isolation and purification solutions?
Why is laboratory automation becoming a strategic priority in the nucleic acid isolation and purification market?
Which type segment holds the largest share in the nucleic acid isolation & purification market?
Which application segment is growing the fastest in the nucleic acid isolation & purification market?
What supports North America’s leadership in nucleic acid isolation and purification?
Which factors are accelerating market growth in Asia Pacific?
Who are the major participants shaping the nucleic acid isolation & purification landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization